Hypoxia-induced secretion of TGF-b1 in mesenchymal stem cell promotes breast cancer cell progression

Cell Transplantation

Volumn 22, Issue 10, 2013, Pages 1869-1882

  Hung, Shun Pei ^a   Yang, Muh Hwa ^a   Tseng, Kuo Fung ^b   Lee, Oscar K ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Breast cancer; Hypoxia; Mesenchymal stem cells (MSCs); Transforming growth factor (TGF )

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL ASSAY; CELL HYPOXIA; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; TUMOR INVASION; TUMOR MICROENVIRONMENT;

BENZAMIDES; BONE MARROW CELLS; BREAST NEOPLASMS; CELL HYPOXIA; CELL MOVEMENT; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DIOXOLES; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HEK293 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MCF-7 CELLS; MESENCHYMAL STROMAL CELLS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RESPONSE ELEMENTS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84884682794     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657954     Document Type: Article

References (32)

1. Barnhart, B. C.; Simon, M. C. Metastasis and stem cell pathways. Cancer Metastasis Rev. 26(2):261-271; 2007.
2. Brown, J. M.; Wilson, W. R. Exploiting tumor hypoxia in cancer treatment. Nat. Rev. Cancer 4(6):437-447; 2004.
3. Chang, J. W.; Hung, S. P.; Wu, H. H.; Wu, W. M.; Yang, A. H.; Tsai, H. L.; Yang, L. Y.; Lee, O. K. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant. 20(2):245-257; 2011.
4. Chang, Y. C.; Shyu, W. C.; Lin, S. Z.; Li, H. Regenerative therapy for stroke. Cell Transplant. 16(2):171-181; 2007.
5. Dumont, N.; Arteaga, C. L. Transforming growth factor-r and breast cancer: Tumor promoting effects of transforming growth factor-g. Breast Cancer Res. 2(2):125-132; 2000.
6. Dunn, L. K.; Mohammad, K. S.; Fournier, P. G.; McKenna, C. R.; Davis, H. W.; Niewolna, M.; Peng, X. H.; Chirgwin, J. M.; Guise, T. A. Hypoxia and TGF-HHdrive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. PLoS One 4(9):e6896, 2009.
7. Hu, M.; Polyak, K. Molecular characterisation of the tumour microenvironment in breast cancer. Eur. J. Cancer 44(18):2760-2765; 2008.
8. Hung, S. C.; Deng, W. P.; Yang, W. K.; Liu, R. S.; Lee, C. C.; Su, T. C.; Lin, R. J.; Yang, D. M.; Chang, C. W.; Chen, W. H.; Wei, H. J.; Gelovani, J. G. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin. Cancer Res. 11(21):7749-7756; 2005.
9. Hung, S. P.; Ho, J. H.; Shih, Y. R.; Lo, T.; Lee, O. K. Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells. J. Orthop. Res. 30(2):260-266; 2012.
10. Karnoub, A. E.; Dash, A. B.; Vo, A. P.; Sullivan, A.; Brooks, M. W.; Bell, G. W.; Richardson, A. L.; Polyak, K.; Tubo, R.; Weinberg, R. A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449(7162):557-563; 2007.
11. Kretzschmar, M. Transforming growth factor-11and breast cancer: Transforming growth factor-c/SMAD signaling defects and cancer. Breast Cancer Res. 2:107-115; 2000.
12. Kuo, T. K.; Hung, S. P.; Chuang, C. H.; Chen, C. T.; Shih, Y. R.; Fang, S. C.; Yang, V. W.; Lee, O. K. Stem cell therapy for liver disease: Parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134(7):2111-2121; 2008.
13. Li, H.; Fan, X.; Houghton, J. Tumor microenvironment: The role of the tumor stroma in cancer. J. Cell. Biochem. 101:805-815; 2007.
14. Lo, T.; Ho, J. H.; Yang, M. H.; Lee, O. K. Glucose reduction prevents replicative senescence and increases mitochondrial respiration in human mesenchymal stem cells. Cell Transplant. 20(6):813-825; 2011.
15. Lu, X.; Kang, Y. Hypoxia and hypoxia-inducible factors: Master regulators of metastasis. Clin. Cancer Res. 16(24):5928-5935; 2010.
16. Martin, F. T.; Dwyer, R. M.; Kelly, J.; Khan, S.; Murphy, J. M.; Curran, C.; Miller, N.; Hennessy, E.; Dockery, P.; Barry, F. P.; O'Brien, T.; Kerin, M. J. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: Stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res. Treat. 124(2):317-326; 2010.
17. Massagué, J.; Blain, S. W.; Lo, R. S. TGF11signaling in growth control, cancer, and heritable disorders. Cell 103(2):295-309; 2000.
18. Nakamizo, A.; Marini, F.; Amano, T.; Khan, A.; Studeny, M.; Gumin, J.; Chen, J.; Hentschel, S.; Vecil, G.; Dembinski, J.; Andreeff, M.; Lang, F. F. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 65(8):3307-3318; 2005.
19. Nishi, H.; Nakada, T.; Hokamura, M.; Osakabe, Y.; Itokazu, O.; Huang, L. E.; Isaka, K. Hypoxia-inducible factor-1 transactivates transforming growth factor-t3 in trophoblast. Endocrinology 145(9):4113-4118; 2004.
20. Nishi, H.; Nakada, T.; Kyo, S.; Inoue, M.; Shay, J. W.; Isaka, K. Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol. Cell. Biol. 2(13):6076-6083; 2004.
21. Potier, E.; Ferreira, E.; Andriamanalijaona, R.; Pujol, J. P.; Oudina, K.; Logeart-Avramoglou, D.; Petite, H. Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone 40(4):1078-1087; 2007.
22. Rosová, I.; Dao, M.; Capoccia, B.; Link, D.; Nolta, J. A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26(8):2173-2182; 2008.
23. Spaeth, E.; Klopp, A.; Dembinski, J.; Andreeff, M.; Marini, F. Inflammation and tumor microenvironments: Defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 15(10):730-738; 2008.
24. Stagg, J. Mesenchymal stem cells in cancer. Stem Cell Rev. 4(2):119-124; 2008.
25. Tang, Y. L.; Zhu, W.; Cheng, M.; Chen, L.; Zhang, J.; Sun, T.; Kishore, R.; Phillips, M. I.; Losordo, D. W.; Qin, G. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ. Res. 104(10):1209-1216; 2009.
26. Xu, J.; Lamouille, S.; Derynck R. TGF-2-induced epithelial to mesenchymal transition. Cell Res. 19(2):156-172; 2009.
27. Yagi, H.; Soto-Gutierrez, A.; Parekkadan, B.; Kitagawa, Y.; Tompkins, R. G.; Kobayashi, N.; Yarmush, M. L. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant. 19(6):667-679; 2010.
28. Yang, M. H.; Wu, M. Z.; Chiou, S. H.; Chen, P. M.; Chang, S. Y.; Liu, C. J.; Teng, S. C.; Wu, K. J. Direct regulation of TWIST by HIF-1oopromotes metastasis. Nat. Cell Biol. 10(3):295-305; 2008.
29. Zavadil, J.; Böttinger, E. P. TGF-22and epithelial-to-mesenchymal transitions. Oncogene 24(37):5764-5774; 2005.
30. Zeisberg, M.; Strultz, F.; Muller, G. A. Role of fibroblast activation in inducing interstitial fibrosis. J. Nephrol. 13(S3):S111-S120; 2000.
31. Zhang, H.; Akman, H. O.; Smith, E. L.; Zhao, J.; Murphy-Ullrich, J. E.; Batuman, O. A. Cellular response to hypoxia involves signaling via Smad proteins. Blood 101(6):2253-2260; 2003.
32. Zhang, H.; Wong, C. C.; Wei, H.; Gilkes, D. M.; Korangath, P.; Chaturvedi, P.; Schito, L.; Chen, J.; Krishnamachary, B.; Winnard, P. T.; Raman, V.; Zhen, L.; Mitzner, W. A.; Sukumar, S.; Semenza, G. L. HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene 31(14):1757-1770; 2012.